Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 4
2016 1
2017 1
2018 1
2019 7
2020 14
2021 10
2022 10
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Kuboki Y, Terazawa T, Masuishi T, Nakamura M, Watanabe J, Ojima H, Makiyama A, Kotaka M, Hara H, Kagawa Y, Sugimoto N, Kawakami H, Takashima A, Kajiwara T, Oki E, Sunakawa Y, Ishihara S, Taniguchi H, Nakajima TE, Morita S, Shirao K, Takenaka N, Ozawa D, Yoshino T. Kuboki Y, et al. Among authors: terazawa t. Br J Cancer. 2023 May;128(10):1897-1905. doi: 10.1038/s41416-023-02212-2. Epub 2023 Mar 4. Br J Cancer. 2023. PMID: 36871043 Free PMC article. Clinical Trial.
Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.
Kawasaki Y, Kakimoto K, Tanaka Y, Shimizu H, Nishida K, Numa K, Kinoshita N, Tatsumi Y, Nakazawa K, Koshiba R, Hirata Y, Ota K, Sakiyama N, Terazawa T, Takeuchi T, Miyazaki T, Goto M, Yokota H, Makizaki Y, Tanaka Y, Nakajima S, Ohno H, Higuchi K, Nakamura S, Nishikawa H. Kawasaki Y, et al. Among authors: terazawa t. Digestion. 2023;104(5):357-369. doi: 10.1159/000528282. Epub 2023 May 11. Digestion. 2023. PMID: 37231829 Free PMC article.
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
Terazawa T, Kato T, Goto M, Ohta K, Satake H, Noura S, Kagawa Y, Kawakami H, Hasegawa H, Yanagihara K, Shingai T, Nakata K, Kotaka M, Hiraki M, Konishi K, Nakae S, Sakai D, Kurokawa Y, Shimokawa T, Tsujinaka T, Satoh T. Terazawa T, et al. Oncologist. 2023 Jul 5;28(7):e565-e574. doi: 10.1093/oncolo/oyac145. Oncologist. 2023. PMID: 35947993 Free PMC article. Clinical Trial.
Volumetric and Functional Regeneration of Remnant Liver With Massive Ascites After Hepatectomy.
Inoue Y, Ishii M, Fujii K, Tomioka A, Yamaguchi T, Yokohama K, Ohama H, Hamamoto H, Osumi W, Tsuchimoto Y, Terazawa T, Ogura T, Masubuchi S, Yamamoto M, Imoto A, Asai A, Fukunishi S, Goto M, Okuda J, Higuchi K, Uchiyama K. Inoue Y, et al. Among authors: terazawa t. Am Surg. 2022 Jun;88(6):1369-1373. doi: 10.1177/0003134820947392. Epub 2020 Sep 11. Am Surg. 2022. PMID: 32915056 No abstract available.
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.
Sunakawa Y, Kuboki Y, Watanabe J, Terazawa T, Kawakami H, Yokota M, Nakamura M, Kotaka M, Sugimoto N, Ojima H, Oki E, Kajiwara T, Yamamoto Y, Tsuji Y, Denda T, Tamura T, Ishihara S, Taniguchi H, Nakajima TE, Morita S, Shirao K, Takenaka N, Ozawa D, Yoshino T. Sunakawa Y, et al. Among authors: terazawa t. Target Oncol. 2024 Jan;19(1):59-69. doi: 10.1007/s11523-023-01027-8. Epub 2024 Jan 9. Target Oncol. 2024. PMID: 38194163 Free PMC article. Clinical Trial.
The Effects of Allogeneic Blood Transfusion in Hepatic Resection.
Inoue Y, Ishii M, Fujii K, Kitada K, Kuramoto T, Takano Y, Matsuo K, Tomioka A, Yamaguchi T, Yokohama K, Ohama H, Harada S, Osumi W, Tsuchimoto Y, Terazawa T, Ogura T, Masubuchi S, Yamamoto M, Imoto A, Asai A, Shirai Y, Inoue M, Fukunishi S, Goto M, Higuchi K, Uchiyama K. Inoue Y, et al. Among authors: terazawa t. Am Surg. 2021 Feb;87(2):228-234. doi: 10.1177/0003134820950285. Epub 2020 Sep 15. Am Surg. 2021. PMID: 32927956
A Prospective Study Regarding the Efficacy and Safety of the BNT162b2 Vaccine in Patients With Solid Malignancies Undergoing Systemic Chemotherapy.
Yamasaki E, Shimamoto F, Nishikawa H, Goto M, Iwamoto M, Kimura K, Ukimura A, Oosaka N, Taniguchi K, Ono F, Terazawa T, Yamaguchi T, Asaishi K, Ikegami T, Uchiyama K, Nakamura S, Higuchi K. Yamasaki E, et al. Among authors: terazawa t. In Vivo. 2022 Nov-Dec;36(6):2780-2789. doi: 10.21873/invivo.13015. In Vivo. 2022. PMID: 36309395 Free PMC article.
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy.
Nakamura Y, Okamoto W, Denda T, Nishina T, Komatsu Y, Yuki S, Yasui H, Esaki T, Sunakawa Y, Ueno M, Shinozaki E, Matsuhashi N, Ohta T, Kato K, Ohtsubo K, Bando H, Hara H, Satoh T, Yamazaki K, Yamamoto Y, Okano N, Terazawa T, Kato T, Oki E, Tsuji A, Horita Y, Hamamoto Y, Kawazoe A, Nakajima H, Nomura S, Mitani R, Yuasa M, Akagi K, Yoshino T. Nakamura Y, et al. Among authors: terazawa t. JCO Precis Oncol. 2022 Feb;6:e2100383. doi: 10.1200/PO.21.00383. JCO Precis Oncol. 2022. PMID: 35188805 Free PMC article.
TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer.
Boku S, Satake H, Ohta T, Mitani S, Kawakami K, Suzuki Y, Matsumoto T, Terazawa T, Yamazaki E, Hasegawa H, Ikoma T, Uemura M, Yamaguchi T, Naito A, Ishizuka Y, Kurokawa Y, Sakai D, Kawakami H, Shimokawa T, Tsujinaka T, Kato T, Satoh T, Kagawa Y. Boku S, et al. Among authors: terazawa t. Future Oncol. 2022 Dec;18(38):4153-4160. doi: 10.2217/fon-2022-0949. Epub 2022 Dec 8. Future Oncol. 2022. PMID: 36475784
43 results